SBFM

Peers: AMRX AMPH VTRS TEVA CPIX RDY RDHL HROW SNOA UPC

Index	-
Market Cap	2.29M
Enterprise Value	-10.77M
Income	-5.83M
Sales	35.35M
Book/sh	230.48
Cash/sh	18.10
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	50
IPO	Oct 30, 2009

P/E	-
Forward P/E	-
PEG	-
P/S	0.06
P/B	0.01
P/C	0.17
P/FCF	-
EV/EBITDA	-
EV/Sales	-0.30
Quick Ratio	3.30
Current Ratio	5.46
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	No / No

EPS (ttm)	-204.52
EPS next Y	-8.00
EPS next Q	-3.40
EPS this Y	86.46%
EPS next Y	79.49%
EPS next 5Y	-
EPS past 3/5Y	92.58% 80.76%
Sales past 3/5Y	102.91% 247.73%
EPS Y/Y TTM	60.85%
Sales Y/Y TTM	-2.74%
EPS Q/Q	70.91%
Sales Q/Q	-1.56%
Earnings	Aug 05
EPS/Sales Surpr.	4.17% 6.90%

Insider Own	78.11%
Insider Trans	0.00%
Inst Own	7.34%
Inst Trans	6.83%
ROA	-17.78%
ROE	-21.92%
ROIC	-20.82%
Gross Margin	29.31%
Oper. Margin	-14.71%
Profit Margin	-16.50%
SMA20	-42.84%
SMA50	-78.74%
SMA200	-97.24%
Trades

Shs Outstand	0.76M
Shs Float	0.17M
Short Float	24.73%
Short Ratio	0.14
Short Interest	0.04M
52W High	464.00 -99.35%
52W Low	2.58 16.66%
Volatility	20.89% 31.84%
ATR (14)	1.60
RSI (14)	27.51
Beta	1.44
Rel Volume	0.32
Avg Volume	299.02K
Volume	4,790

Perf Week	0.33%
Perf Month	-78.11%
Perf Quarter	-87.14%
Perf Half Y	-98.57%
Perf YTD	-98.78%
Perf Year	-99.14%
Perf 3Y	-100.00%
Perf 5Y	-100.00%
Perf 10Y	-100.00%
Recom	1.00
Target Price	1120.00
Prev Close	3.33
Price	3.01
Change %	-9.61%

Oct-22-26 09:00AM	Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing (ACCESSWIRE) -22.47%
Oct-09-26 11:17AM	Sunshine Biopharma Announces Closing of up to $20.4 Million Public Offering (ACCESSWIRE) -21.44%
Oct-08-26 10:40AM	Sunshine Biopharma Prices $6 Million Public Offering at $0.55 Per Unit, Raising Dilution Concerns (InvestorsHub) -38.57%
08:00AM	Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering (ACCESSWIRE)
Sep-24-26 09:00AM	Sunshine Biopharma Launches Generic Zofran(R) in Canada, Expanding Oncology Supportive Care Portfolio (ACCESSWIRE) -8.64%
09:00AM	Loading…
Sep-16-26 09:00AM	Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies (ACCESSWIRE)
Aug-31-26 09:00AM	Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions (ACCESSWIRE)
Aug-26-26 09:00AM	Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer (ACCESSWIRE) +8.77%
Aug-19-26 09:00AM	Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market (ACCESSWIRE)
Aug-07-26 09:00AM	Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market (ACCESSWIRE) -12.14%
Aug-04-26 09:00AM	Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval (ACCESSWIRE) +11.97%
Jul-28-26 08:00AM	Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting (ACCESSWIRE) -6.54%
Jul-20-26 08:30AM	Sunshine Biopharma and University of Arizona Publish Significant New Research Findings (ACCESSWIRE)
Jun-25-26 08:00AM	Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R) (ACCESSWIRE)
Jun-01-26 08:00AM	Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R) (ACCESSWIRE) -5.94%
08:00AM	Loading…
May-29-26 08:00AM	Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology (ACCESSWIRE) -19.84%
May-28-26 09:00AM	Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing (ACCESSWIRE) -25.31%
May-21-26 07:00AM	Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin (ACCESSWIRE) +40.59%
May-19-26 12:05PM	Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering (ACCESSWIRE) -13.73%
May-18-26 12:15PM	Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering (ACCESSWIRE) +79.51%
10:30AM	BC-Most Active Stocks (Associated Press)
Apr-06-26 08:30AM	Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year (ACCESSWIRE) +11.54%
Oct-28-25 02:10PM	Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM) (ACCESSWIRE) -6.12%
07:45AM	Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea (ACCESSWIRE)
Oct-20-25 07:45AM	Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline (ACCESSWIRE) -7.66%
Oct-16-25 07:45AM	Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin (ACCESSWIRE) +13.99%
Oct-14-25 10:45AM	Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM) (ACCESSWIRE) +15.38%
08:50AM	Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM) (ACCESSWIRE)
07:00AM	Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience (ACCESSWIRE)
Oct-09-25 08:00AM	Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections (ACCESSWIRE)
08:00AM	Loading…
Jul-02-25 08:00AM	Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market (ACCESSWIRE) +13.79%
Jun-11-25 08:30AM	Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market (ACCESSWIRE)
May-15-25 04:15PM	Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year (ACCESSWIRE) -5.04% +13.64%
May-06-25 08:30AM	Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market (ACCESSWIRE)
Apr-21-25 08:30AM	Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion (ACCESSWIRE)
Apr-03-25 10:50AM	Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering (ACCESSWIRE) -18.22%
Apr-02-25 01:20PM	Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules (ACCESSWIRE) +8.17%
08:00AM	Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer (ACCESSWIRE)
Apr-01-25 05:09PM	Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year (ACCESSWIRE) +8.90%
Mar-25-25 09:06AM	Sunshine Biopharma signs agreement for rights to market two generic antibiotics (TipRanks)
Mar-10-25 09:00AM	Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market (ACCESS Newswire) -5.02%
Jan-21-25 08:00AM	Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT (ACCESSWIRE)
Jan-15-25 08:00AM	Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer (ACCESSWIRE)
Dec-09-24 07:30AM	Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus (ACCESSWIRE) -10.78%
Dec-04-24 04:05PM	Sunshine Biopharma Launches a New Generic Prescription Drug (ACCESSWIRE) +6.45% +8.75%
Dec-02-24 08:00AM	Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma (ACCESSWIRE) +8.39%
Nov-22-24 08:00AM	Sunshine Biopharma Launches a New Generic Prescription Drug (ACCESSWIRE) +11.32%
Nov-06-24 08:00AM	Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54% (ACCESSWIRE) -6.29%
Sep-26-24 08:00AM	Sunshine Biopharma Launches Two New Generic Prescription Drugs (ACCESSWIRE) +6.97%
Sep-04-24 09:15AM	New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth (GlobeNewswire)
08:30AM	Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 (GlobeNewswire)
08:00AM	Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry (ACCESSWIRE)
Aug-26-24 08:00AM	Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada (ACCESSWIRE)
Aug-19-24 08:00AM	Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61% (ACCESSWIRE) +5.82%
Aug-16-24 10:53PM	SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) -9.60%
Aug-06-24 08:00AM	Sunshine Biopharma Announces Reverse Stock Split (ACCESSWIRE) -22.84%
Jun-28-24 06:00AM	7 F-Rated Growth Stocks to Avoid Right Now: June 2024 (InvestorPlace) -5.09%
Jun-20-24 02:51PM	3 Penny Stocks Ready to Explode Into Dollar Signs by 2028 (InvestorPlace) -11.72%
May-21-24 08:00AM	Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54% (ACCESSWIRE) -17.80%
May-20-24 09:54PM	SBFM Stock Earnings: Sunshine Biopharma Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +5.38%
May-16-24 06:15AM	3 Meme Stocks to Sell That Even Roaring Kitty Can't Save (InvestorPlace)
Apr-19-24 08:00AM	Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R) (ACCESSWIRE) -46.84%
Apr-12-24 09:00AM	Sunshine Biopharma Announces Reverse Stock Split (ACCESSWIRE) -8.04%
Apr-08-24 01:53PM	SBFM Stock Earnings: Sunshine Biopharma Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace) -5.10%
Apr-01-24 08:00AM	Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023 (ACCESSWIRE) +76.03%
Mar-04-24 09:18AM	Why Is Sunshine Biopharma (SBFM) Stock Down 17% Today? (InvestorPlace) -18.95%
Feb-15-24 09:15AM	Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering (ACCESSWIRE) +6.01%
Feb-13-24 09:00AM	Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering (ACCESSWIRE) -63.83%
Dec-04-23 08:30AM	Sunshine Biopharma Moves Principal Office to New York City (GlobeNewswire) -7.59%
Nov-13-23 08:30AM	Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition (ACCESSWIRE) -12.08%
Sep-21-23 09:05PM	Sunshine Biopharma Receives 180-Day Extension To Achieve Nasdaq Minimum Bid Compliance (ACCESSWIRE) -9.68%
Aug-11-23 08:30AM	Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600% (GlobeNewswire)
May-16-23 02:15PM	Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM) (ACCESSWIRE) -9.52%
09:58AM	Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market (GlobeNewswire)
May-12-23 08:00AM	Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market (GlobeNewswire) -18.77%
May-11-23 09:00AM	Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100% (GlobeNewswire) +69.81%
Apr-05-23 08:00AM	Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update (GlobeNewswire) +8.92%
Feb-28-23 07:30AM	Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 Treatment (GlobeNewswire)
Feb-10-23 07:35AM	Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer Compound (GlobeNewswire) +8.10%
Jan-19-23 07:30AM	Sunshine Biopharma Announces Share Repurchase Program (GlobeNewswire) -8.50%
Dec-27-22 08:00AM	Insider Buying: Sunshine Biopharma Inc. (NASDAQ: SBFM) Chief Financial Officer Purchases Shares (News Direct)
Dec-20-22 08:00AM	Sunshine Biopharmas Annual Letter to Shareholders (GlobeNewswire)
Nov-23-22 11:20AM	NASDAQ: SBFM Enters Into A Collaboration Agreement For Its K1.1 Anticancer mRNA Project! (News Direct)
Nov-16-22 10:12AM	Sunshine Biopharma Collaborates For Its Lead mRNA-Based Cancer Program (Benzinga)
08:00AM	Sunshine Biopharma Enters Into a Collaboration Agreement with a Leading Lipid Nanoparticle Formulation Company for Its K1.1 Anticancer mRNA Project (GlobeNewswire)
Nov-13-22 07:52AM	Sunshine Biopharma Third Quarter 2022 Earnings: US$0.077 loss per share (vs US$1.59 loss in 3Q 2021) (Simply Wall St.)
Nov-07-22 09:28AM	What Does Sunshine Biopharmas Acquisition Of Nora Pharma Mean For The Generic Prescription Drugs Market? (News Direct) -11.93%
Oct-20-22 08:00AM	Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue (GlobeNewswire)
07:32AM	EXCLUSIVE: Sunshine Biopharma Acquires Canadian Generic Player For $22M (Benzinga)
Aug-08-22 08:15AM	We're Hopeful That Sunshine Biopharma (NASDAQ:SBFM) Will Use Its Cash Wisely (Simply Wall St.)
Aug-04-22 08:00AM	Sunshine Biopharma Files Its Second Quarter Report With the SEC (GlobeNewswire)
Jul-28-22 08:10AM	Sunshine Biopharma Increases Support for Anti-Coronavirus Collaborative Research With the University of Arizona (GlobeNewswire) -8.00%
Jun-27-22 05:30AM	SBFM: Working to Change the Cancer Fight (Zacks Small Cap Research)
Apr-28-22 04:50PM	Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market (GlobeNewswire) -9.61%
09:20AM	Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ: SBFM) (ACCESSWIRE)
Apr-26-22 08:13AM	Multiple Promising Treatments Accentuate the Bull Case for Sunshine Biopharma (InvestorPlace) -17.71%
12:41AM	Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market (GlobeNewswire)
Apr-25-22 08:00AM	Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells (GlobeNewswire) +20.42%
Apr-19-22 06:45PM	Blockbuster Clinical Results Shine a Positive Light on Sunshine Biopharma (InvestorPlace) +18.50%
02:02PM	EXCLUSIVE: Sunshine Biopharma Looks Ahead In COVID And Cancer Treatments (Benzinga)

Show Previous News

Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in Fort Lauderdale, FL.

ChairmanDr. Steve N. Slilaty Ph.D.

CFOMr. Camille Sebaaly

Chief Commercial OfficerMr. Michel Roy

Chief Development OfficerMr. Malek Chamoun

President of Sunshine Bio Investments IncMr. Robert G. Ferreira

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Sunshine Biopharma Inc

Upgrade your Finviz experience